The case for intravenous arginine stimulation in lieu of mixed-meal tolerance tests as outcome measure for intervention studies in recent-onset type 1 diabetes.
Greenbaum
Carla
C
Benaroya Research Institute, Diabetes Clinical Research, Seattle, Washington 98101, USA. cjgreen@benaroyaresearch.org
Seidel
Kristy
K
Pihoker
Catherine
C
D001120:Arginine / Q000008:administration & dosage; D002096:C-Peptide / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D005951:Glucose Tolerance Test / Q000379:methods*; D006801:Humans; D007275:Injections, Intravenous; D019518:Postprandial Period; D015203:Reproducibility of Results; D016896:Treatment Outcome
D002096:C-Peptide; D001120:Arginine